Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis

NCT01571297 is registered in ClinicalTrials.gov with Motus Therapeutics, Inc. as lead sponsor.

NCT NCT01571297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01571297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Lead sponsor
Motus Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
September 30, 2013
Enrollment
204 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetes mellitus complications, gastroparesis